Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmegaSea is a nutraceutical company specializing in high-potency, pharmaceutical-grade Omega-3 supplements. The company markets its products under the OmegaVia and InnovixLabs brands, focusing on high concentrations of EPA and DHA to support cardiovascular, cognitive, and inflammatory health. OmegaSea utilizes advanced purification technologies, including molecular distillation and CO2 extraction, to ensure purity and minimize contaminants. The company is known for its commitment to transparency, with all products undergoing third-party testing by the International Fish Oil Standards (IFOS) program. Its formulations are designed to provide clinical-strength dosages that are often unavailable in standard retail supplements. Additionally, the company has expanded its portfolio to include specialized probiotics and vitamin supplements under the InnovixLabs label.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OmegaSea.